Vanderbilt University Medical Center (VUMC) is one of 29 sites participating in a national study to determine whether a daily transdermal nicotine patch will have a positive effect on attention and early memory impairment in older adults diagnosed with Mild Cognitive Impairment (MCI). Paul Newhouse, M.D., director of the Center for Cognitive Medicine at VUMC is the national director of the study.

More than 8 million Americans are currently diagnosed with MCI, a condition which affects memory or other thinking skills. Recent evidence shows that adults with MCI are at a higher risk for subsequently developing Alzheimer’s disease.

Follow Vanderbilt on Twitter:   / vanderbiltu  , on Instagram:   / vanderbiltu   and on Facebook:   / vanderbilt  .

See all Vanderbilt social media at http://social.vanderbilt.edu.